These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2484 related articles for article (PubMed ID: 34603293)

  • 21. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma.
    Chen ZA; Tian H; Yao DM; Zhang Y; Feng ZJ; Yang CJ
    Front Oncol; 2021; 11():738477. PubMed ID: 34568075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma.
    Zhang Z; Zhang W; Wang Y; Wan T; Hu B; Li C; Ge X; Lu S
    Front Cell Dev Biol; 2022; 10():792676. PubMed ID: 35295858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma.
    Cao J; Wu L; Lei X; Shi K; Shi L; Shi Y
    Bioengineered; 2021 Dec; 12(1):673-681. PubMed ID: 33622186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of molecular subtypes and prognostic signature for hepatocellular carcinoma based on genes associated with homologous recombination deficiency.
    Lin H; Xie Y; Kong Y; Yang L; Li M
    Sci Rep; 2021 Dec; 11(1):24022. PubMed ID: 34912005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma.
    Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R
    BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.
    Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J
    Front Immunol; 2022; 13():922315. PubMed ID: 35774794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma.
    Lian J; Zhang C; Lu H
    Comput Math Methods Med; 2022; 2022():6284540. PubMed ID: 36035299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
    Xu L; Zheng Q; Liu W
    BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune-related long noncoding RNA signature for predicting survival and immune checkpoint blockade in hepatocellular carcinoma.
    Zhang Y; Zhang L; Xu Y; Wu X; Zhou Y; Mo J
    J Cell Physiol; 2020 Dec; 235(12):9304-9316. PubMed ID: 32330311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma.
    Xie H; Shi M; Liu Y; Cheng C; Song L; Ding Z; Jin H; Cui X; Wang Y; Yao D; Wang P; Yao M; Zhang H
    Front Immunol; 2022; 13():914977. PubMed ID: 36032107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
    Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
    Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of Prognosis and Molecular Mechanism of Ferroptosis in Hepatocellular Carcinoma Based on Bioinformatics Methods.
    Xiong Y; Ouyang Y; Fang K; Sun G; Tu S; Xin W; Wei Y; Xiao W
    Comput Math Methods Med; 2022; 2022():4558782. PubMed ID: 35774297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
    Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T
    Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma.
    Tang B; Zhu J; Li J; Fan K; Gao Y; Cheng S; Kong C; Zheng L; Wu F; Weng Q; Lu C; Ji J
    Cell Commun Signal; 2020 Oct; 18(1):174. PubMed ID: 33115468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer.
    Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y
    J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks.
    Zhao X; Bai Z; Li C; Sheng C; Li H
    Biomed Res Int; 2020; 2020():8765461. PubMed ID: 32382578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of a lipid metabolism-related and immune-associated prognostic signature for hepatocellular carcinoma.
    Hu B; Yang XB; Sang XT
    Cancer Med; 2020 Oct; 9(20):7646-7662. PubMed ID: 32813933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer.
    Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C
    Front Immunol; 2021; 12():783362. PubMed ID: 35154072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel cuproptosis-related lncRNA signature predicts the prognosis and immunotherapy for hepatocellular carcinoma.
    Liu Y; Jiang J
    Cancer Biomark; 2023; 37(1):13-26. PubMed ID: 37005878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
    Yan Z; He M; He L; Wei L; Zhang Y
    Front Immunol; 2021; 12():723271. PubMed ID: 34925311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 125.